Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs710521
rs710521
A 0.740 GeneticVariation GWASDB A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. 20972438

2010

dbSNP: rs710521
rs710521
A 0.740 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014

dbSNP: rs710521
rs710521
0.740 GeneticVariation BEFREE We genotyped rs9642880 G>T on 8q24 and rs710521</span> A>G on 3q28 in a two-stage case-control study of bladder cancer to evaluate the association and further examined the expression of MYC. 19369583

2009

dbSNP: rs710521
rs710521
A 0.740 GeneticVariation GWASDB Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. 18794855

2008

dbSNP: rs710521
rs710521
A 0.740 GeneticVariation GWASDB A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. 20348956

2010

dbSNP: rs710521
rs710521
0.740 GeneticVariation BEFREE Performing a meta-analysis of 5,695 cases and 40,187 controls including all published studies on rs710521, a convincing association with bladder cancer risk was obtained (OR = 1.18; 95% Cl = 1.12-1.25; P < 0.0001). 21063684

2010

dbSNP: rs710521
rs710521
0.740 GeneticVariation BEFREE Fine-mapping of the GWAS signal region led to the identification of twenty SNPs that showed a stronger association with bladder cancer risk than rs710521. 29956121

2018

dbSNP: rs710521
rs710521
0.740 GeneticVariation BEFREE Genome-wide association studies have confirmed association of TP63C/T rs710521, TERTC/T rs2736098, and SLC14A1C/T rs17674580 gene variants with susceptibility to bladder cancer (BC) in European and White population. 25218484

2014

dbSNP: rs1014971
rs1014971
0.720 GeneticVariation BEFREE In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10⁻¹²) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10⁻¹¹) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10⁻⁷) maps to the UGT1A cluster on 2q37.1. 20972438

2010

dbSNP: rs1014971
rs1014971
T 0.720 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014

dbSNP: rs1014971
rs1014971
0.720 GeneticVariation BEFREE SNP rs1014971 was associated with bladder cancer risk, increased APOBEC3B expression, and enrichment with APOBEC-signature mutations in bladder tumors. 27643540

2016

dbSNP: rs1014971
rs1014971
0.720 GeneticVariation GWASDB In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10⁻¹²) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10⁻¹¹) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10⁻⁷) maps to the UGT1A cluster on 2q37.1. 20972438

2010

dbSNP: rs1495741
rs1495741
0.720 GeneticVariation BEFREE Overall, seven of the 14 variants were significantly associated with bladder cancer risk (p = 9.763 × 10(-3) for rs9642880 at 8q24.21, p = 3.004 × 10(-3) for rs2294008 at 8q24.3, p = 0.012 for rs798766 at 4p16.3, p = 0.034 for rs1495741 at </span>8p22, p = 2.306 × 10(-4) for GSTM1, p = 8.507 × 10(-8) for rs17674580 at 18q12.3, p = 7.179 × 10(-4) for rs10936599 at 3q26.2) and the odds ratios (ORs) ranged from 1.13 to 1.65. 24740636

2014

dbSNP: rs1495741
rs1495741
0.720 GeneticVariation GWASDB A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. 20972438

2010

dbSNP: rs1495741
rs1495741
A 0.720 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014

dbSNP: rs1495741
rs1495741
0.720 GeneticVariation BEFREE To quantify the association between rs1495741 and the risk of bladder cancer and to estimate the interaction effect of this genetic variant with smoking, we performed a systematic literature review and meta-analysis involving 14,815 cases and 58,282 controls from 29 studies. 27495060

2016

dbSNP: rs8102137
rs8102137
0.720 GeneticVariation BEFREE In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10⁻¹²) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10⁻¹¹) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10⁻⁷) maps to the UGT1A cluster on 2q37.1. 20972438

2010

dbSNP: rs8102137
rs8102137
C 0.720 GeneticVariation GWASDB In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10⁻¹²) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10⁻¹¹) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10⁻⁷) maps to the UGT1A cluster on 2q37.1. 20972438

2010

dbSNP: rs8102137
rs8102137
C 0.720 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014

dbSNP: rs8102137
rs8102137
0.720 GeneticVariation BEFREE We found that the original GWAS marker rs8102137 represents a group of 47 linked SNPs (with r(2) ≥ 0.7) associated with increased bladder cancer risk. 25320178

2014

dbSNP: rs62185668
rs62185668
A 0.710 GeneticVariation GWASDB Several correlated variants at 20p12, represented by rs62185668, show genome-wide significant association with UBC after combining discovery and replication results (OR = 1.19, P = 1.5 × 10(-11) for rs62185668-A, minor allele frequency = 23.6%). 24861552

2014

dbSNP: rs62185668
rs62185668
0.710 GeneticVariation BEFREE Several correlated variants at 20p12, represented by rs62185668, show genome-wide significant association with UBC after combining discovery and replication results (OR = 1.19, P = 1.5 × 10(-11) for rs62185668-A, minor allele frequency = 23.6%). 24861552

2014

dbSNP: rs2204008
rs2204008
T 0.700 GeneticVariation GWASDB Genome-wide association study identifies multiple loci associated with bladder cancer risk. 24163127

2014

dbSNP: rs833052
rs833052
0.040 GeneticVariation BEFREE Our meta-analysis suggested that rs3025039 (C > T), rs833052 (C > A) and rs25648 (C > T) polymorphisms of VEGF gene increased susceptibility to BCa risk. 30849545

2019

dbSNP: rs833052
rs833052
0.040 GeneticVariation BEFREE The VEGF gene rs3025039C/T and rs833052C/A variants may contribute to the risk of developing BCa, especially in Asian descendants. 30609111

2019